Clinical Trial Update: Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes adding paclitaxel to high-dose chemotherapy for women with metastatic breast cancer, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: St. Louis University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN